SG59183G - Prostanol derivatives - Google Patents

Prostanol derivatives

Info

Publication number
SG59183G
SG59183G SG591/83A SG59183A SG59183G SG 59183 G SG59183 G SG 59183G SG 591/83 A SG591/83 A SG 591/83A SG 59183 A SG59183 A SG 59183A SG 59183 G SG59183 G SG 59183G
Authority
SG
Singapore
Prior art keywords
prostanol
derivatives
prostanol derivatives
Prior art date
Application number
SG591/83A
Other languages
English (en)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of SG59183G publication Critical patent/SG59183G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG591/83A 1977-05-26 1983-09-15 Prostanol derivatives SG59183G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB22319/77A GB1581886A (en) 1977-05-26 1977-05-26 Prostanol derivatives

Publications (1)

Publication Number Publication Date
SG59183G true SG59183G (en) 1984-07-27

Family

ID=10177472

Family Applications (1)

Application Number Title Priority Date Filing Date
SG591/83A SG59183G (en) 1977-05-26 1983-09-15 Prostanol derivatives

Country Status (9)

Country Link
US (1) US4158062A (en:Method)
JP (1) JPS53147045A (en:Method)
DE (1) DE2822751A1 (en:Method)
FR (1) FR2392005A1 (en:Method)
GB (1) GB1581886A (en:Method)
HK (1) HK28784A (en:Method)
IT (1) IT1094851B (en:Method)
MY (1) MY8400370A (en:Method)
SG (1) SG59183G (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512344D0 (en) * 1985-05-15 1985-06-19 May & Baker Ltd Compositions of matter
JPH085794B2 (ja) * 1989-07-27 1996-01-24 株式会社上野製薬応用研究所 高脂質血症処置・血中脂質成分低下剤
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
CN1753680B (zh) * 2002-12-27 2010-12-08 苏坎波公司 用于治疗腹部不适的前列腺素衍生物
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
FR2392005A1 (fr) 1978-12-22
HK28784A (en) 1984-04-06
MY8400370A (en) 1984-12-31
IT1094851B (it) 1985-08-10
DE2822751A1 (de) 1978-12-07
DE2822751C2 (en:Method) 1988-01-28
IT7823915A0 (it) 1978-05-26
FR2392005B1 (en:Method) 1980-04-04
JPS6151584B2 (en:Method) 1986-11-10
JPS53147045A (en) 1978-12-21
GB1581886A (en) 1980-12-31
US4158062A (en) 1979-06-12

Similar Documents

Publication Publication Date Title
IL55387A0 (en) Triphenylalkene derivatives
ZA782129B (en) Hertocyclic derivatives
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876B (en) Beta-haloethylamine derivatives
PH12853A (en) Meta-sulfonamido-benzamide derivatives
EG13665A (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
GB2009180B (en) 25-alkylcholestrerol derivatives
GB2009150B (en) Tetrahydrophtalamide derivatives
SG59183G (en) Prostanol derivatives
PH14637A (en) Oxadiazolopyrimidine derivatives
GB2005261B (en) 2-oxazolydone derivatives
PH13915A (en) Chinazoline derivatives
NZ188863A (en) 2-oxo-hexahydroazepine -piperidine and -pyrrolidine derivatives
IL56042A0 (en) Prostanglandin derivatives
GB2014131B (en) 1-hydrocarbylpyrrole derivatives
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
AU3313978A (en) Everninomicin derivatives
PH15376A (en) 5-phenyl-1h-3-benzazepine derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
GB2008119B (en) Arylsteroid derivatives
AU4129978A (en) Eburnamenine derivatives
GB2060630B (en) Pyrazinoquinoline derivatives
IL54973A0 (en) 3-pyridylhydroxy-prop-1-ene derivatives